NasdaqCM - Nasdaq Real Time Price USD

Eledon Pharmaceuticals, Inc. (ELDN)

Compare
3.0100
0.0000
(0.00%)
As of 2:25:13 PM EDT. Market Open.
All All Favorites Text Statistics Technicals Fibonacci Markings Lines
Loading Chart for ELDN

Recent News: ELDN

View More
We're Hopeful That Eledon Pharmaceuticals (NASDAQ:ELDN) Will Use Its Cash Wisely

We're Hopeful That Eledon Pharmaceuticals (NASDAQ:ELDN) Will Use Its Cash Wisely
Simply Wall St. 25 days ago
Eledon Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Operating and Financial Results

Eledon Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Operating and Financial Results
GlobeNewswire 26 days ago
Eledon Pharmaceuticals to Participate in Leerink Partners Global Healthcare Conference

Eledon Pharmaceuticals to Participate in Leerink Partners Global Healthcare Conference
GlobeNewswire last month
Eledon Pharmaceuticals Announces Use of Tegoprubart as Key Component of Immunosuppression Regimen in its Second Transplant of a Genetically Modified Pig Kidney into a Human

Eledon Pharmaceuticals Announces Use of Tegoprubart as Key Component of Immunosuppression Regimen in its Second Transplant of a Genetically Modified Pig Kidney into a Human
GlobeNewswire 2 months ago
Eledon Pharmaceuticals to Participate in Guggenheim Securities SMID Cap Biotech Conference

Eledon Pharmaceuticals to Participate in Guggenheim Securities SMID Cap Biotech Conference
GlobeNewswire 2 months ago
Eledon Pharmaceuticals Highlights Recent Business Milestones and Provides 2025 Outlook

Eledon Pharmaceuticals Highlights Recent Business Milestones and Provides 2025 Outlook
GlobeNewswire 3 months ago
Eledon Pharmaceuticals, Inc.'s (NASDAQ:ELDN) market cap dropped US$48m last week; individual investors who hold 57% were hit as were institutions

Eledon Pharmaceuticals, Inc.'s (NASDAQ:ELDN) market cap dropped US$48m last week; individual investors who hold 57% were hit as were institutions
Simply Wall St. 4 months ago
Eledon Pharmaceuticals Announces Recent Business Highlights and Third Quarter 2024 Financial Results

Eledon Pharmaceuticals Announces Recent Business Highlights and Third Quarter 2024 Financial Results
GlobeNewswire 4 months ago
Eledon Pharmaceuticals to Participate in Guggenheim Securities Inaugural Healthcare Innovation Conference

Eledon Pharmaceuticals to Participate in Guggenheim Securities Inaugural Healthcare Innovation Conference
GlobeNewswire 5 months ago
Eledon Pharmaceuticals Announces Pricing of $85 Million Underwritten Offering of Common Stock and Pre-Funded Warrants

Eledon Pharmaceuticals Announces Pricing of $85 Million Underwritten Offering of Common Stock and Pre-Funded Warrants
GlobeNewswire 5 months ago
Eledon Pharmaceuticals Announces Positive Initial Data from Subjects with Type 1 Diabetes Treated with Tegoprubart as Part of an Immunosuppression Regimen Following Islet Transplantation in Investigator-Initiated Trial at UChicago Medicine

Eledon Pharmaceuticals Announces Positive Initial Data from Subjects with Type 1 Diabetes Treated with Tegoprubart as Part of an Immunosuppression Regimen Following Islet Transplantation in Investigator-Initiated Trial at UChicago Medicine
GlobeNewswire 5 months ago
View More

Related Tickers

OSTX OS Therapies Incorporated
1.5300
+6.34%
 
KLRS Kalaris Therapeutics, Inc.
6.63
+2.55%
 
ELTX Elicio Therapeutics, Inc.
5.07
+1.71%
 
DSGN Design Therapeutics, Inc.
3.2701
-1.50%
 
OLMA Olema Pharmaceuticals, Inc.
4.2750
+1.54%
 
XBIT XBiotech Inc.
3.0000
-5.66%
 
DMAC DiaMedica Therapeutics Inc.
3.3650
-4.13%
 
OVID Ovid Therapeutics Inc.
0.2732
-4.62%
 
ARMP Armata Pharmaceuticals, Inc.
1.1900
+3.48%
 
IKT Inhibikase Therapeutics, Inc.
1.9400
+2.12%